Logo image
Back
Stratified Temporal Risk of Skin Cancer by Age Associated with Hydrochlorothiazide: A Retrospective Cohort Study Using the TriNetX Database
Conference poster   Peer reviewed

Stratified Temporal Risk of Skin Cancer by Age Associated with Hydrochlorothiazide: A Retrospective Cohort Study Using the TriNetX Database

Taylor Merkle, Celter Odango and Erum Ilyas
Journal of the American Academy of Dermatology, v 95(1), AB86
Jul 2026
DOI: https://doi.org/10.1016/j.jaad.2026.04.1647

Abstract

Hydrochlorothiazide (HCTZ) is known to have photosensitizing properties with recent FDA labeling updates warning of its increased risk of nonmelanoma skin cancer (NMSC). [1] Only few and some conflicting studies exist, especially regarding melanoma and significant confounders. [2,3] This retrospective cohort study utilizing the TriNetX database investigates age and temporal associations between the initiation of HCTZ as monotherapy for hypertension (HTN) and the diagnosis of basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), and melanoma. Six adult (age >18) cohorts were created with (1) HTN (ICD10: I10) as control and (2) HTN with HCTZ; then further stratified by age from 18 to 49 and 50 to 75. Outcomes assessed were BCC, cSCC, and melanoma at 5 and 10 years. HCTZ usage in cohorts aged 50 to 75 years old was significantly (p<0.05) associated with an increased risk ratio of BCC (RR=2.518, 2.332) and cSCC (RR=2.446, 2.423) at 5 and 10 years respectively and with melanoma (RR=1.315) only at 10 years . This study refines prior reports of HCTZ usage associated with development of BCC and cSCC particularly in older adults while controlling for confounders such as concurrent antihypertensives and smoking. The association with melanoma in the older aged cohorts and with longer durations of HCTZ usage suggests a role for cumulative actinic damage among other risk factors. We highlight the need for increased dermatological surveillance and counseling among this vulnerable population, especially for those over the age of 50 on sustained HCTZ therapy.

Metrics

1 Record Views

Details

Logo image